C1orf174_A430005L14Rik Inhibitors
Chemical inhibitors of C1orf174_A430005L14Rik encompass a variety of compounds that interfere with signaling cascades and kinase activities, thereby reducing the functional capacity of the protein. Staurosporine, a broad-spectrum kinase inhibitor, may impede C1orf174_A430005L14Rik by inhibiting kinases that phosphorylate the protein, leading to its diminished activity. Rapamycin, targeting the mTOR pathway, is another inhibitor that could indirectly inhibit C1orf174_A430005L14Rik by attenuating the signaling cascade necessary for its activation. Similarly, LY 294002 and Wortmannin target the PI3K/Akt pathway, and their inhibitory action would lead to a decrease in C1orf174_A430005L14Rik activity if it is regulated downstream of PI3K. SB 203580 and PD 98059, by selectively inhibiting p38 MAPK and MEK respectively, would suppress the MAPK/ERK pathway, a potential regulator of C1orf174_A430005L14Rik activity.
Complementing these are U0126 and SP600125, which act on different MAPK pathway components, MEK1/2, and JNK respectively, to inhibit any C1orf174_A430005L14Rik activity that is contingent upon MAPK signaling. NF449's inhibition of the G-protein Gsα subunit could lead to reduced cAMP levels, thereby affecting C1orf174_A430005L14Rik if it is cAMP-dependent. PP 2 disrupts Src family kinase signaling, which could be an upstream regulator of C1orf174_A430005L14Rik. KN-93 and BAPTA/AM operate by modulating calcium-dependent processes; KN-93 by inhibiting CaMKII and BAPTA/AM by chelating calcium ions, both potentially leading to the diminished activity of C1orf174_A430005L14Rik if its function relies on calcium-mediated signaling. Collectively, these inhibitors work on distinct yet interconnected biochemical pathways, converging on the functional inhibition of C1orf174_A430005L14Rik without affecting its expression levels.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent non-selective inhibitor of protein kinases. It can inhibit a wide range of kinases which may indirectly lead to the inhibition of C1orf174_A430005L14Rik if the protein's function is regulated by phosphorylation processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can disrupt the mTOR signaling pathway. If C1orf174_A430005L14Rik is involved in pathways regulated by mTOR, such as cell growth and proliferation, rapamycin would indirectly inhibit its functional activity by diminishing the signaling cascade that activates the protein. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is a specific inhibitor of PI3K. It would decrease PI3K-mediated signaling pathways, which, if C1orf174_A430005L14Rik is involved in such pathways, would lead to a diminution of its activity due to less upstream signaling activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a selective inhibitor of p38 MAPK. It diminishes the p38 MAPK signaling pathway. If C1orf174_A430005L14Rik's activity is modulated by this pathway, the inhibition of p38 MAPK would result in decreased functional activity of the protein. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a specific MEK inhibitor, which would lead to the inhibition of the MAPK/ERK pathway. If C1orf174_A430005L14Rik functions downstream of or is regulated by the MAPK/ERK pathway, its activity would diminish due to the reduced pathway signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor. It would decrease PI3K/Akt signaling, and if C1orf174_A430005L14Rik is implicated in this pathway, its activity would be indirectly diminished. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, part of the MAPK pathway. By inhibiting JNK, it would diminish any downstream signaling that relies on JNK, potentially decreasing the activity of C1orf174_A430005L14Rik if it is JNK-dependent. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
NF449 is a potent and selective inhibitor of Gsα-subunit of G-proteins. Inhibition of Gsα can lead to decreased cAMP levels, which if C1orf174_A430005L14Rik activity is cAMP-dependent, would result in diminished protein function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP 2 is a selective inhibitor of Src family kinases. If the functional activity of C1orf174_A430005L14Rik is regulated by Src kinase signaling, PP 2 would indirectly lead to a decrease in its activity. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). If C1orf174_A430005L14Rik is modulated by CaMKII, inhibition by KN-93 would result in diminished activity of the protein. | ||||||